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background:   Thoracic external beam radiation therapy (XRT) for cancer is associated with a variety of long-term cardiotoxic effects and 
may predispose to development of atrial fibrillation (AF). We aimed to examine presenting characteristics and comorbidities at time of 
incident AF in XRT-treated cancer survivors to see if they differed from the general AF population.
Methods:  In this retrospective analysis of 4,618 Olmstead County residents (Minnesota, USA) diagnosed with incident AF between 1980 
and 2000, we identified all patients who had previously received curative thoracic XRT (>30 Gray) for cancer at Mayo Clinic since 1971. 
Baseline clinical characteristics and comorbidities at time of AF diagnosis in XRT-treated patients were compared with the general AF 
population.
results:  We identified 39 patients with incident AF previously treated with XRT for cancer (mean XRT-AF interval 4.6±4.9 years). 
Compared with the general AF population (n=4,579), patient age and rates of previous CAD, MI, PCI, valvular heart disease, and stroke 
at time of AF diagnosis were similar, although XRT-treated patients more frequently had prior CABG (18 vs 9%; p=0.04). The XRT cohort 
had lower rates of prior CHF (11 vs 29%; p=0.002), diabetes (5 vs 18%; p=0.03) and renal disease (5 vs 17%; p=0.05). The XRT cohort 
more frequently had prior atrial flutter (21 vs 11%; p=0.05), and AF heart rate at time of diagnosis was faster (122.2 vs 111.4 bpm; p=0.05) 
than the general AF population. XRT-treated patients were more likely to have undergone noncardiac surgery in the 15 days prior to AF 
diagnosis (16 vs 8%; p=0.02).
Conclusion:  At time of AF diagnosis, patients with prior XRT are less likely to have a history of heart failure, and rates of concomitant 
coronary artery disease and valvular heart disease are the similar versus the general AF population. The higher frequency of concomitant 
atrial flutter suggests the mechanism of arrhythmogenesis may be different in XRT-treated patients. Faster heart rates at AF diagnosis 
may result from effects of XRT on the autonomic nervous system. The high percentage of patients with postoperative AF after noncardiac 
surgery in this population merits further study.
